Back to Search
Start Over
US FDA issues warning letters to two Chinese firms regarding data quality and integrity concerns, violative lab practices
- Source :
- PharmaBiz. September 13, 2024
- Publication Year :
- 2024
-
Abstract
- The US Food and Drug Administration (FDA) issued warning letters to two Chinese nonclinical testing laboratories, citing both for laboratory oversight failures and animal care violations that raise concerns about [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.808556708